Safety and tolerability of acetylcysteine and pirfenidone combination therapy in idiopathic pulmonary fibrosis: a randomised, double-blind, placebo-controlled, phase 2 trial
Year: 2016
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: The Lancet Respiratory Medicine
Institutions: Asklepios Fachkliniken München-Gauting, German Center for Lung Research, Ludwig-Maximilians-Universität München, Aarhus University Hospital, Assistance Publique – Hôpitaux de Paris, Hôpital Bichat-Claude-Bernard, Université Paris Diderot, Justus-Liebig-Universität Gießen, Medical University of Graz, Karolinska University Hospital, Karolinska Institutet, Royal Brompton & Harefield NHS Foundation Trust, Universitair Ziekenhuis Leuven, Heidelberg University, Centre Hospitalier Universitaire de Lille, Hôpital Albert Calmette, Genentech, University of Turin
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2346218824
